The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Juxtapid
lomitapide mesylate · LOMITAPIDE MESYLATE 2 mg/1 · Capsule · Oral · Chiesi USA, Inc.
NDC 10122-0402-28 · 28 CAPSULE in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $59,762.07 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Juxtapid
Regulatory
- Application
- NDA203858
- TE code
- —
- Approval date
- Dec 21, 2012
- Patents / exclusivity
- 12 patents, 6 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NPP | Feb 25, 2029 |
| exclusivity | NPP | Feb 25, 2029 |
| exclusivity | NPP | Feb 25, 2029 |
| exclusivity | NPP | Feb 25, 2029 |
| exclusivity | NPP | Feb 25, 2029 |
| exclusivity | NS | Feb 25, 2029 |
| patent | 12472172 | Jul 29, 2041 |
| patent | 12472172 | Jul 29, 2041 |
| patent | 12472172 | Jul 29, 2041 |
| patent | 12472172 | Jul 29, 2041 |
| patent | 12472172 | Jul 29, 2041 |
| patent | 7932268 | Aug 19, 2027 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of lomitapide mesylate (Capsule)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Catalent Pharma Solution, LLC | LOMITAPIDE MESYLATE 5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Amryt Pharmaceuticals DAC | LOMITAPIDE MESYLATE 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Amryt Pharmaceuticals DAC | LOMITAPIDE MESYLATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Catalent Pharma Solution, LLC | LOMITAPIDE MESYLATE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chiesi USA, Inc. | LOMITAPIDE MESYLATE 5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chiesi USA, Inc. | LOMITAPIDE MESYLATE 10 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chiesi USA, Inc. | LOMITAPIDE MESYLATE 2 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chiesi USA, Inc. | LOMITAPIDE MESYLATE 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chiesi USA, Inc. | LOMITAPIDE MESYLATE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Catalent Pharma Solution, LLC | LOMITAPIDE MESYLATE 20 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Catalent Pharma Solution, LLC | LOMITAPIDE MESYLATE 10 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Pharma Packaging Solutions, LLC dba Tjoapack LLC | LOMITAPIDE MESYLATE 20 mg/1 | Jul 15, 2026 | Jul 23, 2026 |
| Pharma Packaging Solutions, LLC dba Tjoapack LLC | LOMITAPIDE MESYLATE 30 mg/1 | Jul 15, 2026 | Jul 22, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Juxtapid — NDC 10122-0402-28," retrieved September 3, 2026, https://drugdashboards.com/drug/10122040228.
Free to cite with attribution — see how the data is put together.